35
Views
14
CrossRef citations to date
0
Altmetric
FIBROMYALGIA SYNDROME

Assessment of Patients with Fibromyalgia Syndrome

Pages 75-83 | Published online: 10 Jul 2009

REFERENCES

  • Mease P. Fibromyalgia Syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 2005; 32: 6–21
  • Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160–172
  • Burckhardt C S, Clark S R, Bennett R M. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991; 18: 728–733
  • Mease P J, Clauw D J, Arnold L M, Goldenberg D L, Witter J, Williams D A, Simon L S, Strand C V, Bramson C, Martin S, Wright T M, Littman B, Wernicke J F, Gendreau R M, Crofford L J. Fibromyalgia syndrome. J Rheumatol 2005; 32: 2270–2277
  • Mease P, Arnold L M, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell I J, Simon L S, Spaeth M, Williams D A, Crofford L J. Fibromyalgia Syndrome. J Rheumatol 2007; 34: 1415–1425
  • Turk D C, Dworkin R, Allen R R, Bellamy N, Brandenburg N, Carr D B, Cleeland C, Dionne R, Farrar J T, Galer B S, Hewitt D J, Jadad A R, Katz N P, Kramer L D, Manning D C, McCormick C G, McDermott M P, McGrath P, Quessy S, Rappaport B A, Robinson J P, Royal M A, Simon L S, Stauffer J W, Stein W, Tollett J, Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003; 106: 337–345
  • Turk D C, Dworkin R, Burke L B, Gershon R, Rothman M, Scott J, Allen R R, Atkinson J H, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar J T, Haythornthwaite J A, Hertz S, Jadad A R, Jensen M P, Kellstein D, Kerns R D, Manning D C, Martin S, Max M B, McDermott M P, McGrath P, Moulin D E, Nurmikko T, Quessy S, Raja S, Rappaport B A, Rauschkolb C, Robinson J P, Royal M A, Simon L, Stauffer J W, Stucki G, Tollett J, von Stein T, Wallace M S, Wernicke J, White R E, Williams A C, Witter J, Wyrwich K W. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 2006; 125: 208–215
  • Rowe G, Wright G, Bolger F. Delphi. A reevaluation of research and theory. Technological Forecasting and Social Change 1991; 39: 235–251
  • Delbecq A L, Vande Ven A H, Gustafson D H. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes. Scott-Foresman & Co., Glenview, IL 1975
  • Farrar J T, Portenoy R K, Berlin J A, Kinman J L, Strom B L. Defining the clinically important difference in pain outcome measures. Pain 2000; 88: 287–294
  • Farrar J T, Young J P, Jr., La Moreaux L, Werth J L, Poole R M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149–158
  • Gendreau M, Hufford M R, Stone A A. Measuring clinical pain in chronic widespread pain: Selected methodological issues. Best Pract Res Clin Rheumatol 2003; 17: 575–592
  • Gracely R H, Grant M A, Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 2003; 17: 593–609
  • Henriksson C M. Longterm effects of fibromyalgia on everyday life. A study of 56 patients. Scand J Rheumatol 1994; 23: 36–41
  • Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975; 1: 277–299
  • Melzack R. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191–197
  • Mengshoel A M, Forre O. Pain and fatigue in patients with rheumatic disorders. Clin Rheumatol 1993; 12: 515–521
  • Littlejohn G. A database for fibromyalgia. Rheum Dis Clin North Am 1995; 21: 527–557
  • Gendreau R M, Thorn M D, Gendreau J F, Kranzler J D, Ribeiro S, Gracely R H, Williams D A, Mease P, McLean S A, Clauw D. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005; 32: 1975–1985
  • Crofford L, Rowbotham M, Mease P, Russell I J, Dworkin R H, Corbin A E, Young J P, Jr., La Moreaux L K, Martin S A, Sharma U. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis and Rheum 2005; 52: 1264–1273
  • Arnold L M, Lu Y, Crofford L J, Wohlreich M, Detke M J, Iyengar S, Goldstein D J. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50: 2974–2984
  • Arnold L M, Rosen A, Pritchett Y L, D'Souza D, Goldstein D J, Iyengar S, Wernicke J. Duloxetine in the treatment of fibromyalgia in women-results from two clinical trials. Pain 2005; 119: 5–15
  • Martinez-Lavin M, Lopez S, Medina M, Nava A. Use of the Leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. Semin Arthritis Rheum 2003; 32: 407–411
  • Okifuji A, Turk D C, Sinclair J D, Starz T W, Marcus D A. A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 1997; 24: 377–383
  • Holman A J, Myers R R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis and Rheum 2005; 52: 2495–2505
  • Russell I J, Bennett R M, Michalek J E. Sodium oxybate relieves pain and improves sleep in fibromyalgia syndrome [FMS]: A randomized, double-blind, placebo-controlled, multi-center clinical trial. 2005, ACR/ARHP Scientific Meeting Program Book Supplement: Late-breaking abstracts
  • Belza B L, Henke C J, Yelin E H, Epstein W V, Gilliss C L. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993; 42: 93–99
  • Smets E M, Garssen B, Bonke B, De Haes J C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 315–325
  • Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health Qual Life Outcomes 2003; 1: 79
  • Krupp L B, La Rocca N G, Muir-Nash J, Steinberg A D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123
  • Stewart A L, Hays R D, Ware J E. The M OS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724–735
  • Jenkins C D, Stanton B A, Niemcryk S J, Rose R M. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988; 41: 313–321
  • Ware J EJ, Sherbourne C D. The M OS 36-Item Short Form Health Survey (SF-36): Conceptual framework and item selection. Med Care 1992; 30: 473–483
  • Neumann L, Berzak A, Buskila D. Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: Utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 2000; 29: 400–408
  • Cieza A, Stucki G, Weigl M, Kullman L, Stoll T, Kamen L, Kostanjsek N, Walsh N. ICF Core Sets for chronic widespread pain. J Rehabil Med 2004; 44: 63–68
  • Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G. ICF linking rules: An update based on lessons learned. J Rehabil Med 2005; 37: 212–218
  • McGahuey C A, Gelenber A J, Laukes C A, Moreno F A, Delgado P L, McKnight K M, Manber R. The Arizona Sexual Experiences Scale (ASEX): Reliability and validity. J Sex Marital Ther 2000; 26: 25–40
  • Beck A T, Ward C H, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–751
  • Sheehan D V, Lecrubier Y, Sheehan K H, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 1998; 20: 22–57
  • Beck A T, Epstein N, Brown G, Steer R A. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893–897
  • Turk D C, Monarch E S, Williams A D. Psychological evaluation of patients diagnosed with fibromyalgia syndrome: A comprehensive approach. Rheum Dis Clin North Am 2002; 28: 219–233
  • Retherford R D. Statistical methods for casual analysis. John Wiley & Sons, New York 1993
  • Glass J M. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: New trends and future directions. Curr Rheumatol Rep 2006; 8: 425–429
  • Seidenberg M, Haltiner A, Taylor M A, Hermann B B, Wyler A. Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol 1994; 16: 93–104
  • Dunkl P R, Taylor A G, McConnell G G, Alfano A P, Conaway M R. Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol 2000; 27: 2683–2691
  • Simms R W, Felson D T, Goldenberg D L. Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 1991; 18: 1558–1563

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.